Skip to main content
SpringerLink
Log in

Normal pregnancy in a woman with nesidioblastosis treated with somatostatin analog octreotide

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Objective: We report the case of a 36-yr-old woman with nesidioblastosis treated throughout pregnancy with high doses of octreotide. We studied the course of blood glucose, foetal growth and development. Methods: Blood samples were obtained every month throughout pregnancy and taken at birth from the umbilical cord. Sonography was performed repeatedly to monitor foetal growth. Results: The daily dose of octreotide was adapted to blood glucose levels: a dose of 1000 μg was infused during the first part of pregnancy, then it was decreased step by step during the last trimester of gestation. An elective cesarean section was performed at 32 weeks of gestation. High octreotide concentrations were obtained during the first part of gestation (range 2888–5021 pg/ml). During the third trimester of pregnancy blood glucose increased despite high insulin levels attesting physiological insulin-resistance. Plasma levels of placental GH and IGF-1 levels were similar to those observed in a normal pregnancy. Despite the presence of octreotide in the umbilical cord, TSH, free T4, PRL and pituitary GH concentrations were normal at birth. The female newborn (weight 3520 g, length 52 cm) had no malformation, and presented with normal postnatal development. Conclusion: Our study demonstrates that: 1) octreotide treatment can be effective in controlling endogenous hyperinsulinism during pregnancy; 2) octreotide does not affect physiological changes during pregnancy such as insulin-resistance or placental GH level; 3) exposure of the foetus to octreotide throughout pregnancy does not induce any malformation and does not affect foetal development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. De Lonlay-Debeney P, Fournet JC, Martin D, et al. Persistent hyperinsulinemic hypoglycaemia in the newborn and infants. Arch Pediatr 1998, 5: 1347–52.

    Article  PubMed  Google Scholar 

  2. Cade A, Walters M, Puntis JW, Arthur RJ, Stringer MD. Pancreatic exocrine and endocrine function after pancreatectomy for persistent hyperinsulinemic hypoglycaemia of infancy. Arch Dis Child 1998, 79: 435–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. De Lonlay P, Fournet JC, Rahier J, et al. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycaemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 1997, 100: 802–7.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Rubens R, Carlier A, Thiery M, Vermeulen A. Pregnancy complicated by insulinoma. Case report. Br J Obstet Gynaecol 1977, 84: 543–7.

    Article  CAS  PubMed  Google Scholar 

  5. Fassnacht M, Capeller B, Arlt W, Steck T, Allolio B. Octreotide LAR treatment throughout pregnancy in an acromegalic woman. Clin Endocrinol (Oxf.) 2001, 55: 411–5.

    Article  CAS  Google Scholar 

  6. Colao A, Merola B, Ferone D, Lombardi G. Acromegaly. J Clin Endocrinol Metab 1997, 82: 2777–81.

    Article  CAS  PubMed  Google Scholar 

  7. Landolt AM, Schmid J, Wimpfheimer C, Karlsson ER, Boerlin V. Successful pregnancy in a previously infertile woman treated with SMS 201-995 for acromegaly. N Engl J Med 1989, 320: 671–2.

    CAS  PubMed  Google Scholar 

  8. Montini M, Pagani G, Gianola D, Pagani MD, Piolini R, Camboni MG. Acromegaly and primary amenorrhea: ovulation and pregnancy induced by SMS 201–995 and bromocriptine. J Endocrinol Invest 1990, 13: 193.

    Article  CAS  PubMed  Google Scholar 

  9. Paiva I, Barros L, Gomes F. Successful pregnancy in an acromegalic women treated with octreotide. Program and abstracts of the IVth European Congress of Endocrinology, Sevilla, Spain, 1998, P2–99 (abstract)}.

    Google Scholar 

  10. De Menis E, Billeci D, Marton E, Gussoni G. Uneventful pregnancy in an acromegalic patient treated with slow release lanreotide: a case report. J Clin Endocrinol Metab 1999, 84: 1489.

    Article  PubMed  Google Scholar 

  11. Mozas J, Ocon E, Lopez de la Torre M, Suarez AM, Miranda JA, Herruzo AJ. Successful pregnancy in a woman with acromegaly treated with somatostatin analog (octreotide) prior to surgical resection. Int J Gynaecol Obstet 1999, 65: 71–3.

    Article  CAS  PubMed  Google Scholar 

  12. Takeuchi K, Funakoshi T, Oomori S, Maruo T. Successful pregnancy in an acromegalic woman treated with octreotide. Obstet Gynecol 1999, 93: 848.

    Article  CAS  PubMed  Google Scholar 

  13. Sanchez R, Boix E, del Pino Navarro M, Pico A. Pregnancy in an acromegalic patient treated with lanreotide and bromocryptin. Med Clin (Barc) 1999, 113: 198.

    CAS  Google Scholar 

  14. Hierl T, Ziegler R, Kasperk C. Pregnancy in persistent acromegaly. Clin Endocrinol (Oxf.) 2000, 53: 262–3.

    Article  CAS  Google Scholar 

  15. Caron P, Gerbeau C, Pradayrol L, Simonetta C, Bayard F. Successful pregnancy in an infertile woman with a thyrotropin secreting macroadenoma treated with somatostatin analog (octreotide). J Clin Endocrinol Metab 1996, 81: 1164–8.

    CAS  PubMed  Google Scholar 

  16. Campbell IL, Harrison LC, Ley CJ, Colman PG, Ellis DW. Nesidioblastosis and multifocal pancreatic islet cell hyperplasia in an adult. Clinicopathologic features and in vitro pancreatic studies. Am. J Clin Pathol 1985, 84: 534–41.

    CAS  PubMed  Google Scholar 

  17. Kane C, Shepherd RM, Squires PE, et al. Loss of functional KATP channels in β-cells causes persistent hyperinsulinemic hypoglycaemia of infancy. Nat Med 1996, 2: 1344–7.

    Article  CAS  PubMed  Google Scholar 

  18. Garner PR, Tsang R. Insulinoma complicating pregnancy presenting with hypoglycaemic coma after delivery: a case report and review of the litterature. Obstet Gynecol 1989, 73: 847–9.

    CAS  PubMed  Google Scholar 

  19. Smythe AR 2nd, McFarland KF, Yousufuddin M., Meredith WD. Multiple endocrine adenomatosis type I in pregnancy. Am J Obstet Gynecol 1990, 163: 1037–9.

    Article  PubMed  Google Scholar 

  20. Galun E, Ben-Yehuda A, Belatzki J. Insulinoma complicating pregnancy: case report and review of the literature. Am J Obstet Gynecol 1986, 155: 64–5.

    Article  CAS  PubMed  Google Scholar 

  21. Rubens R, Carlier A, Thiery M. Pregnancy complicated by insulinoma. Case report. Br J Obstet Gynaecol 1977, 84: 543–7.

    Article  CAS  PubMed  Google Scholar 

  22. Mills JL, Jonavic L, Knopp R. Physiological reduction in fasting plasma glucose concentration in the first trimester of normal pregnancy: the diabetes in early pregnancy study. Metabolism 1998, 47: 1140–4.

    Article  CAS  PubMed  Google Scholar 

  23. Hornnes PJ. On the decrease of glucose tolerance in pregnancy. A review. Diabete Metab 1985, 11: 310–5.

    CAS  PubMed  Google Scholar 

  24. Sorenson RL, Brelje TC. Adaptation of islets of Langerhans to pregnancy: β-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 1997, 29: 301–7.

    Article  CAS  PubMed  Google Scholar 

  25. Evain-Brion D. Hormonal regulation of fetal growth. Horm Res 1994, 42: 207–14.

    Article  CAS  PubMed  Google Scholar 

  26. Frankenne F, Closset J, Gomez F, Scippo ML, Smal J, Hennen G. The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J Clin Endocrinol Metab 1988, 66: 1171–80.

    Article  CAS  PubMed  Google Scholar 

  27. Caron P, Buscail L, Beckers A, et al. Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy. J Clin Endocrinol Metab 1997, 82: 3771–6.

    CAS  PubMed  Google Scholar 

  28. Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol 1999, 20: 157–98.

    Article  CAS  PubMed  Google Scholar 

  29. Reed DK, Korytko AI, Hipkin RW, Wehrenberg WB, Schonbrunn A, Cuttler L. Pituitary somatostatin receptor (sst) 1–5 expression during rat development: age-dependent expression of sst2. Endocrinology 1999, 140: 4739–44.

    CAS  PubMed  Google Scholar 

  30. Laquerriere A, Leroux P, Gonzalez B, Bodenant C, Tayot J, Vaudry H. Somatostatin receptors in the human cerebellum during development. Brain Res 1992, 573: 251–9.

    Article  CAS  PubMed  Google Scholar 

  31. Goodyer CG, Branchaud CL, Lefebvre Y. Effects of growth hormone (GH)-releasing factor and somatostatin on GH secretion from early to midgestation human foetal pituitaries. J Clin Endocrinol Metab 1993, 76: 1259–64.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Rangueil University Hospital Centre, France, 1, Avenue Jean Poulhès, TSA 50032, 31059

    C. Boulanger, D. Vezzosi, A. Bennet, F. Lorenzini & P. Caron MD

  2. Department of Biochemistry, La Grave University Hospital Centre, Toulouse, France

    J. Fauvel

Authors
  1. C. Boulanger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Vezzosi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Bennet
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Lorenzini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Fauvel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Caron MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Caron MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boulanger, C., Vezzosi, D., Bennet, A. et al. Normal pregnancy in a woman with nesidioblastosis treated with somatostatin analog octreotide. J Endocrinol Invest 27, 465–470 (2004). https://doi.org/10.1007/BF03345293

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345293

Key-words

Search

Navigation